409 related articles for article (PubMed ID: 26179411)
1. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
Manabe Y; Ino T; Yamanaka K; Kosaka K
Psychogeriatrics; 2016 May; 16(3):202-8. PubMed ID: 26179411
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
Mori S; Mori E; Iseki E; Kosaka K
Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
[TBL] [Abstract][Full Text] [Related]
5. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial.
Mori E; Ikeda M; Nakai K; Miyagishi H; Nakagawa M; Kosaka K
J Neurol Sci; 2016 Jul; 366():184-190. PubMed ID: 27288803
[TBL] [Abstract][Full Text] [Related]
7. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?
Pakrasi S; Thomas A; Mosimann UP; Cousins DA; Lett D; Burn DJ; O'Brien JT; McKeith IG
Int J Geriatr Psychiatry; 2006 Aug; 21(8):719-21. PubMed ID: 16858742
[TBL] [Abstract][Full Text] [Related]
9. Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report.
Ozaki A; Nishida M; Koyama K; Ishikawa K; Nishikawa T
Psychogeriatrics; 2012 Dec; 12(4):255-8. PubMed ID: 23279148
[TBL] [Abstract][Full Text] [Related]
10. Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy.
Kazui H; Adachi H; Kanemoto H; Yoshiyama K; Wada T; Tokumasu Nomura K; Tanaka T; Ikeda M
Psychiatry Res; 2017 May; 251():312-318. PubMed ID: 28236784
[TBL] [Abstract][Full Text] [Related]
11. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial.
Mori E; Ikeda M; Kosaka K;
Ann Neurol; 2012 Jul; 72(1):41-52. PubMed ID: 22829268
[TBL] [Abstract][Full Text] [Related]
12. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of donepezil in dementia with Lewy bodies.
Szigeti K; Hafeez MU
Drugs Today (Barc); 2015 Oct; 51(10):579-90. PubMed ID: 26583300
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study.
Mori E; Ikeda M; Iseki E; Katayama S; Nagahama Y; Ohdake M; Takase T
Psychogeriatrics; 2024 May; 24(3):542-554. PubMed ID: 38439118
[TBL] [Abstract][Full Text] [Related]
16. Donepezil for behavioural disorders associated with Lewy bodies: a case series.
Lanctôt KL; Herrmann N
Int J Geriatr Psychiatry; 2000 Apr; 15(4):338-45. PubMed ID: 10767734
[TBL] [Abstract][Full Text] [Related]
17. Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB).
Rosenbloom MH; Finley R; Scheinman MM; Feldman MD; Miller BL; Rabinovici GD
Alzheimer Dis Assoc Disord; 2010; 24(2):209-11. PubMed ID: 20505440
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
19. Successful use of donepezil for the treatment of dementia with Lewy bodies.
Rojas-Fernandez CH
Ann Pharmacother; 2001 Feb; 35(2):202-5. PubMed ID: 11215841
[TBL] [Abstract][Full Text] [Related]
20. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study.
Samuel W; Caligiuri M; Galasko D; Lacro J; Marini M; McClure FS; Warren K; Jeste DV
Int J Geriatr Psychiatry; 2000 Sep; 15(9):794-802. PubMed ID: 10984725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
